Barry Ticho S.'s most recent trade in Stoke Therapeutics Inc was a trade of 1,051 shares done at an average price of $26.2 . Disclosure was reported to the exchange on Oct. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.16 per share. | 01 Oct 2026 | 1,051 | 19,059 (0%) | 0% | 26.2 | 27,494 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.51 per share. | 01 Sep 2026 | 3,945 | 21,710 (0%) | 0% | 30.5 | 120,370 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.06 per share. | 01 Sep 2026 | 1,600 | 20,110 (0%) | 0% | 31.1 | 49,691 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2026 | 10,000 | 30,422 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 14 Aug 2026 | 10,000 | 0 | - | - | Performance Stock Units | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.01 per share. | 14 Aug 2026 | 4,525 | 25,897 (0%) | 0% | 32.0 | 144,833 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.47 per share. | 14 Aug 2026 | 242 | 25,655 (0%) | 0% | 32.5 | 7,857 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 28.95 per share. | 03 Aug 2026 | 5,907 | 21,691 (0%) | 0% | 29.0 | 171,008 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.45 per share. | 03 Aug 2026 | 1,269 | 20,422 (0%) | 0% | 29.5 | 37,377 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.62 per share. | 01 Jul 2026 | 6,728 | 28,098 (0%) | 0% | 32.6 | 219,434 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.27 per share. | 01 Jul 2026 | 500 | 27,598 (0%) | 0% | 33.3 | 16,634 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.58 per share. | 01 Jun 2026 | 1,795 | 34,826 (0%) | 0% | 30.6 | 54,891 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.79 per share. | 01 May 2026 | 2,243 | 36,621 (0%) | 0% | 32.8 | 73,548 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 01 Apr 2026 | 1,838 | 38,864 (0%) | 0% | 32.7 | 60,029 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.28 per share. | 17 Mar 2026 | 6,100 | 41,384 (0%) | 0% | 31.3 | 190,831 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.28 per share. | 17 Mar 2026 | 6,100 | 41,384 (0%) | 0% | 31.3 | 190,831 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.74 per share. | 17 Mar 2026 | 3,577 | 50,071 (0%) | 0% | 32.7 | 117,109 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.74 per share. | 17 Mar 2026 | 3,577 | 50,071 (0%) | 0% | 32.7 | 117,109 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.38 per share. | 17 Mar 2026 | 2,587 | 47,484 (0%) | 0% | 33.4 | 86,342 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.38 per share. | 17 Mar 2026 | 2,587 | 47,484 (0%) | 0% | 33.4 | 86,342 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.99 per share. | 17 Mar 2026 | 1,461 | 40,702 (0%) | 0% | 30.0 | 43,815 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.99 per share. | 17 Mar 2026 | 1,461 | 40,702 (0%) | 0% | 30.0 | 43,815 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.19 per share. | 17 Mar 2026 | 1,365 | 42,163 (0%) | 0% | 2.2 | 2,989 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 17 Mar 2026 | 1,365 | 83,035 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.19 per share. | 17 Mar 2026 | 1,365 | 42,163 (0%) | 0% | 2.2 | 2,989 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.79 per share. | 17 Mar 2026 | 483 | 40,901 (0%) | 0% | 31.8 | 15,354 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.79 per share. | 17 Mar 2026 | 483 | 40,901 (0%) | 0% | 31.8 | 15,354 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.85 per share. | 17 Mar 2026 | 103 | 40,798 (0%) | 0% | 32.9 | 3,384 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.85 per share. | 17 Mar 2026 | 103 | 40,798 (0%) | 0% | 32.9 | 3,384 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 15 Mar 2026 | 13,100 | 13,100 | - | - | Restricted Stock Units | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 13,100 | 32,898 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 13,100 | 32,898 (0%) | 0% | 0 | - | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 15 Mar 2026 | 10,750 | 32,250 | - | - | Restricted Stock Units | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 10,750 | 53,648 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 10,750 | 53,648 (0%) | 0% | 0 | - | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 15 Mar 2026 | 10,000 | 20,000 | - | - | Restricted Stock Units | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 10,000 | 42,898 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 10,000 | 42,898 (0%) | 0% | 0 | - | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 17 Feb 2026 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 17 Feb 2026 | 40,000 | 40,000 | - | - | Restricted Stock Units | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 03 Dec 2025 | 10,000 | 0 | - | - | Performance Stock Units | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2025 | 10,000 | 25,156 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2025 | 10,000 | 25,156 (0%) | 0% | 0 | - | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.35 per share. | 03 Dec 2025 | 1,989 | 19,798 (0%) | 0% | 31.3 | 62,346 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.35 per share. | 03 Dec 2025 | 1,989 | 19,798 (0%) | 0% | 31.3 | 62,346 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.33 per share. | 03 Dec 2025 | 1,673 | 21,787 (0%) | 0% | 31.3 | 52,416 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.33 per share. | 03 Dec 2025 | 1,673 | 21,787 (0%) | 0% | 31.3 | 52,416 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.76 per share. | 03 Dec 2025 | 1,373 | 23,783 (0%) | 0% | 30.8 | 42,238 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.76 per share. | 03 Dec 2025 | 1,373 | 23,783 (0%) | 0% | 30.8 | 42,238 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.32 per share. | 03 Dec 2025 | 323 | 23,460 (0%) | 0% | 31.3 | 10,115 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.32 per share. | 03 Dec 2025 | 323 | 23,460 (0%) | 0% | 31.3 | 10,115 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 11,981 | 19,176 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 01 Dec 2025 | 11,981 | 0 | - | - | Restricted Stock Units | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 11,981 | 19,176 (0%) | 0% | 0 | - | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.56 per share. | 01 Dec 2025 | 1,244 | 17,932 (0%) | 0% | 29.6 | 36,775 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.56 per share. | 01 Dec 2025 | 1,244 | 17,932 (0%) | 0% | 29.6 | 36,775 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.85 per share. | 01 Dec 2025 | 1,225 | 15,156 (0%) | 0% | 30.8 | 37,788 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.85 per share. | 01 Dec 2025 | 1,225 | 15,156 (0%) | 0% | 30.8 | 37,788 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.34 per share. | 01 Dec 2025 | 789 | 16,381 (0%) | 0% | 30.3 | 23,937 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.34 per share. | 01 Dec 2025 | 789 | 16,381 (0%) | 0% | 30.3 | 23,937 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.14 per share. | 01 Dec 2025 | 762 | 17,170 (0%) | 0% | 30.1 | 22,968 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.14 per share. | 01 Dec 2025 | 762 | 17,170 (0%) | 0% | 30.1 | 22,968 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.22 per share. | 03 Nov 2025 | 3,776 | 9,350 (0%) | 0% | 25.2 | 95,247 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.22 per share. | 03 Nov 2025 | 3,776 | 9,350 (0%) | 0% | 25.2 | 95,247 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.02 per share. | 03 Nov 2025 | 1,455 | 7,895 (0%) | 0% | 26.0 | 37,860 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.02 per share. | 03 Nov 2025 | 1,455 | 7,895 (0%) | 0% | 26.0 | 37,860 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.54 per share. | 03 Nov 2025 | 600 | 7,295 (0%) | 0% | 27.5 | 16,524 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.54 per share. | 03 Nov 2025 | 600 | 7,295 (0%) | 0% | 27.5 | 16,524 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.35 per share. | 03 Nov 2025 | 100 | 7,195 (0%) | 0% | 29.4 | 2,935 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.35 per share. | 03 Nov 2025 | 100 | 7,195 (0%) | 0% | 29.4 | 2,935 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 23.64 per share. | 01 Oct 2025 | 5,343 | 13,126 (0%) | 0% | 23.6 | 126,316 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 23.64 per share. | 01 Oct 2025 | 5,343 | 13,126 (0%) | 0% | 23.6 | 126,316 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.87 per share. | 02 Sep 2025 | 5,501 | 18,469 (0%) | 0% | 19.9 | 109,325 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.87 per share. | 02 Sep 2025 | 5,501 | 18,469 (0%) | 0% | 19.9 | 109,325 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 18.24 per share. | 18 Aug 2025 | 2,805 | 23,970 (0%) | 0% | 18.2 | 51,158 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 18.24 per share. | 18 Aug 2025 | 2,805 | 23,970 (0%) | 0% | 18.2 | 51,158 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 14 Aug 2025 | 20,000 | 20,000 | - | - | Performance Stock Units | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 10,000 | 26,775 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 14 Aug 2025 | 10,000 | 10,000 | - | - | Performance Stock Units | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 10,000 | 26,775 (0%) | 0% | 0 | - | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.82 per share. | 01 Aug 2025 | 4,504 | 16,775 (0%) | 0% | 12.8 | 57,724 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.82 per share. | 01 Aug 2025 | 4,504 | 16,775 (0%) | 0% | 12.8 | 57,724 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.63 per share. | 01 Jul 2025 | 4,503 | 21,279 (0%) | 0% | 11.6 | 52,379 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.63 per share. | 01 Jul 2025 | 4,503 | 21,279 (0%) | 0% | 11.6 | 52,379 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 02 Jun 2025 | 6,471 | 25,782 (0%) | 0% | 10.0 | 64,892 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 02 Jun 2025 | 6,471 | 25,782 (0%) | 0% | 10.0 | 64,892 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 02 Jun 2025 | 1,745 | 32,253 (0%) | 0% | 10 | 17,450 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 02 Jun 2025 | 1,745 | 32,253 (0%) | 0% | 10 | 17,450 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 01 May 2025 | 22,790 | 33,998 (0%) | 0% | 10.0 | 228,543 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 01 May 2025 | 22,790 | 33,998 (0%) | 0% | 10.0 | 228,543 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 01 May 2025 | 3,841 | 56,788 (0%) | 0% | 10 | 38,410 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 01 May 2025 | 3,841 | 56,788 (0%) | 0% | 10 | 38,410 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 18 Mar 2025 | 64,000 | 64,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 18 Mar 2025 | 43,000 | 43,000 | - | - | Restricted Stock Units | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.67 per share. | 18 Mar 2025 | 3,884 | 63,962 (0%) | 0% | 8.7 | 33,674 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.67 per share. | 18 Mar 2025 | 3,884 | 63,962 (0%) | 0% | 8.7 | 33,674 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.27 per share. | 18 Mar 2025 | 3,333 | 60,629 (0%) | 0% | 8.3 | 27,564 | Common Stock |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.27 per share. | 18 Mar 2025 | 3,333 | 60,629 (0%) | 0% | 8.3 | 27,564 | - |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 13,100 | 57,846 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | 15 Mar 2025 | 13,100 | 26,200 | - | - | Restricted Stock Units | ||
| Stoke Therapeutics Inc | Mr. Barry S. Ticho, M.D.,PhD | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 13,100 | 57,846 (0%) | 0% | 0 | - |